Navigation Links
Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
Date:8/28/2008

-- Company provides revenue guidance and strategic plan 2009/ 2010 --

LAVAL, QC, Aug. 28 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today reported its financial results for the fourth quarter and year ended May 31, 2008. The Company achieved record revenues for the fourth quarter of fiscal year 2008 and has achieved its sixth consecutive year of record revenues.

Financial Highlight 2008

------------------------

- Revenues for the fiscal year ended May 31, 2008 totalled a record

$10,264,000, a 26.3% increase compared to the fiscal year ended May 31,

2007 with revenues of $8,126,000.

- The Company increased its sales in all geographic areas during the

fiscal year ended May 31, 2008, with the exception of Canada. Total

North America sales grew by 6.34% to $6,749,000 and in the United

States, sales increased by 15.1% to $5,765,000. Sales in Europe

increased by 10.5% to $1,727,000 and sales in the Asia-Pacific region

rose considerably by 727% to $1,788,000.

- The Company substantially increased its productions, generating growth

of 54% in sales volume, which is, however, not fully reflected in the

revenue increase, due to the impact of the U.S. dollar devaluation on

more than 82% of the Company's sales.

- EBITDA(1) for fiscal year 2008, ended May 31, 2008 decreased to

$1,020,000 compared to the previous fiscal year, ended May 31, 2007, of

$1,504,000, mainly due to expenses related to the devaluation of the

U.S. dollar, implementation of compliance with internal control

regulations (52-109, Sarbanes-Oxley) and in an ERP(2) management

software and quality assurance program.

Neptune Strategic Plan 2009/ 2010

---------------------------------

In its 2009 and 2010 strategic plan, the Company plans to focus on strengthen
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
6. Neptune Technologies receives GRAS notification in the United States
7. Neptune Technologies expands into medicinal markets in Asia Pacific
8. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
9. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
10. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Antonio, TX (PRWEB) August 29, 2014 ... and ISO 13485:2003 certified, GAMP® 5 compliant imaging ... awarded an international Phase II clinical trial to ... lymphoma. , Throughout this trial, Intrinsic Imaging will ... not limited to, protocol and charter development, site ...
(Date:8/28/2014)... 2014 Best Sanitizers, Inc., the first ... hand sanitizer, asks food processors and food handling professionals ... sanitizer they’re currently using to Best Sanitizers’ Alpet® ... critical to fighting cross-contamination and the spread of pathogens ... there are key criteria that make a hand sanitizer ...
(Date:8/28/2014)... are important devices in spintronics, an electronic which ... electrons but also on their spin and the ... electric into magnetic signals and vice versa. Recently, ... the Institute of Physics at Johannes Gutenberg University ... Prague, and Japan, has for the first time ...
(Date:8/28/2014)... month, executives from clinical trial marketing firm BBK Worldwide will ... Patient-Centered Clinical Trials 2014 , to be held at the ... 4-5. Patient recruitment experts Bonnie A. Brescia , ... insights on the benefits of employing an effective patient engagement ... to mobile apps – can be used to drive study ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2
... Anesiva,Inc. (Nasdaq: ANSV ) announced today the ... of its common stock at $4.05 per share, ... on December 12, 2007, for,approximately $45 million in ... $50 million if the underwriters,over-allotment option described below ...
... 13 Synosia Therapeutics today,announced the appointment of ... officer, effective immediately., Dr Blanc, who will ... joins from Syngenta, where he created and led ... and an,experienced biotech entrepreneur, Dr. Blanc helped biotech ...
... Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) announced today ... webcast to provide an update on indiplon Thursday,morning, December ... a.m. Eastern,Time (6:00 a.m. Pacific Time)., Participants can ... 785-424-1071 (International) using the conference,ID: NEURO12. The call can ...
Cached Biology Technology:Anesiva Raises $45 Million in Common Stock Offering 2Synosia Therapeutics Announces Appointment of Chief Business Officer 2
(Date:8/31/2014)... Montral, August 31, ... Nature Neuroscience journal by, Sylvain Williams, PhD, and his ... University Institute and McGill University, opens the door towards better ... as well of the role of an essential element of ... In 2009, they developed a unique approach namely, the ...
(Date:8/29/2014)... Until recently, little has been known about what genetic ... team of scientists, one of whom is a University ... showing that genes controlling the development of the brain ... domestication., The study was published Aug. 28 in ... It is online at http://www.sciencemag.org/ ., The domestication ...
(Date:8/29/2014)... the type and number of connections in transcription factor ... robustness in a study published in PLOS Computational ... the assortativity signature contributes to a network,s resilience against ... the out-out assortativity of TFN models has a greater ... three types of assortativity," said Dov A. Pechenick, PhD, ...
Breaking Biology News(10 mins):Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3Assortativity signatures of transcription factor networks contribute to robustness 2
... MADISON Failing to see the forest for ... declining health of Wisconsin,s forest ecosystems. Even areas ... as forests are increasingly fragmented by roads and development, ... fields, housing tracts, and strip malls, say University of ...
... rings are acclaimed in representing natural climate archives. ... growth of these annual rings depend mainly on temperature ... slight seasonal variations, the correlation is not so ... for Geosciences and their colleagues of the Australian National ...
... Versartis, Inc., an emerging company developing novel biologics ... presented data for its long-acting product candidates, VRS-317 (hGH-rPEG) ... (IL-1ra-rPEG) for treatment of type 1 and type 2 ... DC. Versartis, through a unique licensing agreement with Amunix, ...
Cached Biology News:Isolated forest patches lose species, diversity 2Isolated forest patches lose species, diversity 3Australia's climate: Drought and flooding in annual rings of tropical trees 2Versartis presents positive preclinical data on 2 product candidates at ENDO 09 2
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Complete cell culture media with cytokines...
...
BD IMagnet 1 each...
Biology Products: